ArticleScientific reports2024
Mobile photon counting detector CT with multi material decomposition methods for neuroimaging of patients in intensive care unit.
Article in Scientific reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Spectral CT and Photon-counting Detector CT: Principles and Applications in Neuroradiology.Radiology. Imaging cancer · 2026Review
- Accurate iodine quantification and residual error reduction with principal component analysis multimaterial decomposition using spectral CT.Medical physics · 2026Article
- Clinical applications of portable CT scanners.The British journal of radiology · 2025Review
- Automatic future remnant segmentation in liver resection planning.International journal of computer assisted radiology and surgery · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The photon-counting detector computed tomography (PCD-CT) is a promising new technology that provides more spectral information in medical imaging. PCD-CT enables bedside imaging in the neuro intensive care unit (neuro ICU) for patients with life-threatening conditions such as brain hemorrhage and ischemic stroke. The primary purpose of this study is to evaluate a multi-material decomposition algorithm available on PCD-CT, dubbed MD Plus, to differentiate between contrast agent and hemorrhage in hyperdense lesions. A certified multi-energy phantom was used to validate its performance with various x-ray exposure conditions and locations of contrast agent. The results from the quantitative analysis of multi-energy phantoms and the clinical cases of patients in the ICU demonstrated that MD Plus can accurately differentiate between the contrast agent and the hemorrhage. The extended MD Plus algorithm, including virtual non-contrast (VNC) and bone removal, was also validated for various clinical applications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.